Innovation as an Attribute of the Sustainable Development of Pharmaceutical Companies DOI Open Access
Ewa Chomać-Pierzecka

Sustainability, Год журнала: 2025, Номер 17(6), С. 2417 - 2417

Опубликована: Март 10, 2025

An orientation towards strengthening the competitiveness of enterprises through an effective response to market expectations is nowadays associated with sustainable development. Despite articulation role innovative solutions in this respect, literature has not sufficiently explored issue. Hence, aim article was analyse impact innovation on development pharmaceutical sector operating Poland. For purposes study, scope and spectrum reference for entities diagnosed based results a diagnostic survey. In part in-depth assessment surveyed conducted. The above performed using appropriately selected methods qualitative quantitative nature, including economic analytical techniques (cause-effect analysis, dependency analysis). research sample made up companies Poland; therefore, refer only these there are no grounds transferring them general population country under study. This paper’s findings indicate that idea creating added value, growing out broad concern social, environmental aspects, determined by approach enhances security, responding societal expectations, while at same time aiming maximise activities. Companies invest more heavily achieve better development, as confirmed research. aware directing expenditure into strengthen their ability respond effectively strongest implementation product innovation.

Язык: Английский

Innovation as an Attribute of the Sustainable Development of Pharmaceutical Companies DOI Open Access
Ewa Chomać-Pierzecka

Sustainability, Год журнала: 2025, Номер 17(6), С. 2417 - 2417

Опубликована: Март 10, 2025

An orientation towards strengthening the competitiveness of enterprises through an effective response to market expectations is nowadays associated with sustainable development. Despite articulation role innovative solutions in this respect, literature has not sufficiently explored issue. Hence, aim article was analyse impact innovation on development pharmaceutical sector operating Poland. For purposes study, scope and spectrum reference for entities diagnosed based results a diagnostic survey. In part in-depth assessment surveyed conducted. The above performed using appropriately selected methods qualitative quantitative nature, including economic analytical techniques (cause-effect analysis, dependency analysis). research sample made up companies Poland; therefore, refer only these there are no grounds transferring them general population country under study. This paper’s findings indicate that idea creating added value, growing out broad concern social, environmental aspects, determined by approach enhances security, responding societal expectations, while at same time aiming maximise activities. Companies invest more heavily achieve better development, as confirmed research. aware directing expenditure into strengthen their ability respond effectively strongest implementation product innovation.

Язык: Английский

Процитировано

0